ISCO International Stem Cell CORP

Price (delayed)

$0.58

Market cap

$4.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$8.48M

Highlights
The gross margin is up by 2.7% year-on-year
The company's EPS rose by 24% YoY but it fell by 6% QoQ
ISCO's net income is up by 21% YoY but it is down by 8% QoQ
The equity has plunged by 65% YoY and by 8% from the previous quarter
The quick ratio has dropped by 55% since the previous quarter and by 25% year-on-year

Key stats

What are the main financial stats of ISCO
Market
Shares outstanding
7.77M
Market cap
$4.51M
Enterprise value
$8.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.32
Earnings
Revenue
$6.43M
EBIT
-$2.83M
EBITDA
-$2.31M
Free cash flow
-$1.03M
Per share
EPS
-$0.38
Free cash flow per share
-$0.14
Book value per share
-$0.62
Revenue per share
$0.85
TBVPS
$0.63
Balance sheet
Total assets
$6.02M
Total liabilities
$6.42M
Debt
$5.1M
Equity
-$4.7M
Working capital
-$1.68M
Liquidity
Debt to equity
-1.08
Current ratio
0.65
Quick ratio
0.33
Net debt/EBITDA
-1.72
Margins
EBITDA margin
-36%
Gross margin
60.5%
Net margin
-45.9%
Operating margin
-45.6%
Efficiency
Return on assets
-49.3%
Return on equity
N/A
Return on invested capital
-60.4%
Return on capital employed
-218.3%
Return on sales
-44.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ISCO stock price

How has the International Stem Cell stock price performed over time
Intraday
0%
1 week
13.73%
1 month
-21.62%
1 year
-25.64%
YTD
56.76%
QTD
-13.57%

Financial performance

How have International Stem Cell's revenue and profit performed over time
Revenue
$6.43M
Gross profit
$3.89M
Operating income
-$2.93M
Net income
-$2.95M
Gross margin
60.5%
Net margin
-45.9%
The operating income has grown by 38% YoY but it has contracted by 4% from the previous quarter
The revenue has contracted by 33% YoY and by 10% from the previous quarter
The gross profit has declined by 31% year-on-year and by 11% since the previous quarter
ISCO's net income is up by 21% YoY but it is down by 8% QoQ

Growth

What is International Stem Cell's growth rate over time

Valuation

What is International Stem Cell stock price valuation
P/E
N/A
P/B
N/A
P/S
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.32
The company's EPS rose by 24% YoY but it fell by 6% QoQ
The equity has plunged by 65% YoY and by 8% from the previous quarter
The revenue has contracted by 33% YoY and by 10% from the previous quarter
ISCO's P/S is 13% above its last 4 quarters average of 0.6 but 2.9% below its 5-year quarterly average of 0.7

Efficiency

How efficient is International Stem Cell business performance
ISCO's return on invested capital is up by 37% year-on-year but it is down by 11% since the previous quarter
The company's return on sales fell by 20% QoQ and by 16% YoY
The ROA has contracted by 12% from the previous quarter

Dividends

What is ISCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ISCO.

Financial health

How did International Stem Cell financials performed over time
The total assets is 6% lower than the total liabilities
International Stem Cell's current ratio has shrunk by 56% QoQ and by 19% YoY
The quick ratio has dropped by 55% since the previous quarter and by 25% year-on-year
The equity has plunged by 65% YoY and by 8% from the previous quarter
International Stem Cell's debt has increased by 33% YoY and by 18% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.